Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT)

SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating the officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) for breaches of fiduciary duty, mismanagement, corporate waste, and violations of the securities laws. Corcept is a pharmaceutical company that develops medications to treat severe metabolic, oncologic, and psychiatric disorders. Corcept's drug Korylm is a cortisol receptor blocker used to control hyperglycemia.

If you would like more information about Corcept Therapeutics Incorporated's misconduct, click here.

Corcept Therapeutics Incorporated (CORT) is Being Investigated for Illicit Sales Practices

On December 8, 2021, Corcept disclosed that "[o]n November 15, 2021, the Company received a records subpoena from the U.S. Attorney's Office for the District of New Jersey (the 'NJ USAO') pursuant to Section 248 of the Health Insurance Portability and Accountability Act of 1996 (HIPPA) seeking information relating to the sale and promotion of Korlym, Corcept's relationships with and payments to health care professionals who can prescribe or recommend Korlym and prior authorizations and reimbursement for Korlym." The Company further disclosed that "[t]he NJ USAO has informed Corcept that it is investigating whether any criminal or civil violations by Corcept occurred in connection with the matters referenced in the subpoena."

On this news, Corcept's stock price fell $3.71 per share, or 16.91%, to close at $18.23 per share on December 8, 2021.

Corcept Therapeutics Incorporated (CORT) shareholders have legal options. If you own shares of Corcept Therapeutics Incorporated, contact us to learn more about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Corcept Therapeutics Incorporated settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:CORT

Release Summary

Corcept Therapeutics Incorporated (CORT) is Being Investigated for Illicit Sales Practices

Release Versions

$Cashtags

Hashtags

#securitiesviolations

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Firm Robbins LLP Informs Investors of the BellRing Brands, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired BellRing Brands, Inc. (NYSE: BRBR) securities between November 19, 2024 and August 4, 2025. BellRing develops, markets, and sells "convenient nutrition" products such as ready-to-drink (“RTD”) protein shakes, powders, bars, and other protein enriched food products, primarily under the brand name Premier Protein. For more information, submit a...

Shareholder Rights Law Firm Robbins LLP Urges Varonis Systems, Inc. Stockholders to Seek Information About Their Rights Against VRNS

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Varonis Systems, Inc. (NASDAQ: VRNS) securities between February 5, 2025 and October 28, 2025. Varonis is a global security company that provides software products and services to discover and classify critical data, remediate exposures, and detect advanced threats with the help of AI-powered technologies. For more information, submit a form,...

Shareholder Rights Law Firm Robbins LLP Urges Klarna Group plc Stockholders to Seek Information About Their Rights Against KLAR

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Klarna Group plc (NASDAQ: KLAR) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Klarna's September 10, 2025, initial public offering ("IPO"). Klarna purports to be a “technology-driven payments company, with operations spanning multiple countries.” For more information, submit...

Back to Newsroom